Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer.
We are adding to our talented team as we execute our commercial launch, advance our research and development efforts, and build our internal manufacturing capabilities. Iovance is headquartered in the San Francisco Bay Area. Our Iovance Cell Therapy Center (iCTC), a state-of-the-art manufacturing facility, is located in Philadelphia. We also have a research site in Tampa, Florida.
Any information expressed by Iovance is subject to the risk factors and information on forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: https://ir.iovance.com/sec-filings
Company Details
- Employees
- 1.01K
- Founded
- -
- Address
- 825 Industrial Rd, Suite 400,united States
- Phone
- (212)946-4856
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- iovance.com
- Keywords
- Immuno Oncology, Autologous Cell Therapy, Tumor Infiltrating Lymphocytes (TIL), Novel Cancer Immunotherapies, cell therapy.
- HQ
- San Carlos, California
Iovance Biotherapeutics, Inc. Questions
Iovance Biotherapeutics, Inc.'s helpline number is (212)946-4856
Iovance Biotherapeutics, Inc.'s website is iovance.com
Iovance Biotherapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/iovance
Iovance Biotherapeutics, Inc. has
1.01K employees.
View email and phone details for 1.01K
employees at Iovance Biotherapeutics, Inc..
Iovance Biotherapeutics, Inc.'s industry is
Biotechnology Research
Iovance Biotherapeutics, Inc.'s top competitors are
Bristol Myers Squibb,
Gilead Sciences,
Amgen,
Vertex Pharmaceuticals,
Spark Therapeutics, Inc.,
Allogene Therapeutics,
Kite Pharma,
Adaptimmune,
Legend Biotech.
Iovance Biotherapeutics, Inc.'s categories are Biotechnology Research
Iovance Biotherapeutics, Inc.'s founding year is 2007
